drugset / Trial / NCT02767479

Comparison of Rabeprazole and Esomperazole for the Eradication of H. Pylori

NCT02767479

Phase 3 Completed 200 enrolled Hamamatsu University
RandomizedParallel-groupOpen-labelTreatment

Summary

Patients infected with H. pylori are treated with rabeprazole 10 mg bid, AMPC 750 mg bid and CAM 200 mg bid or esomeprazole 20 mg bid, AMPC 750 mg bid and CAM 200 mg bid. Eradication rates are compared. Patients who have ever failed in eradication by CAM-based regimen are treated with rabeprazole 10 mg bid, AMPC 750 mg bid and MNZ 250 mg bid or esomeprazole 20 mg bid, AMPC 750 mg bid and MNZ 250 mg bid.

Timeline

Start
2012-07
Primary completion
2016-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Esomeprazole Small molecule 20 mg
Comparator Rabeprazole Small molecule 10 mg
Comparator AMPC Unknown 750 mg
Comparator CAM Unknown 200 mg